Picture
SEARCH
What are you looking for?
Need help finding what you are looking for? Contact Us
Compare

PUBLISHER: KBV Research | PRODUCT CODE: 1261125

Cover Image

PUBLISHER: KBV Research | PRODUCT CODE: 1261125

North America Antimicrobial Susceptibility Testing Market Size, Share & Industry Trends Analysis Report By Application, By Method, By Type, By End User, By Product, By Country and Growth Forecast, 2022 - 2028

PUBLISHED:
PAGES: 110 Pages
DELIVERY TIME: 1-2 business days
SELECT AN OPTION
PDF (Single User License)
USD 1500
PDF (Site License)
USD 1800
PDF (Enterprisewide License)
USD 2520

Add to Cart

The North America Antimicrobial Susceptibility Testing Market would witness market growth of 5.4% CAGR during the forecast period (2022-2028).

The overuse and misuse of antibiotics leading to antimicrobial resistance (AMR) and the rising utilization of antimicrobial susceptibility testing by biotechnological, biopharmaceutical, and pharmaceutical companies are major factors for the rapid expansion of the antimicrobial susceptibility testing market.

In addition, the increasing incidence of hospital-acquired infections (HAIs), the expansion of the patient population (especially in emerging nations), and the government's greater awareness of the need to battle antimicrobial resistance are anticipated to propel the market even further. Moreover, testing evaluates therapeutic services given by clinics, hospitals, and national infectious disease control and preventive programs. As a result of mutations in microbial genes, scientists are now compelled to undertake continuous surveillance of resistance patterns.

According to the Antibiotic Resistant Risks in the United States report, funding from the CDC's AR Solutions Initiative will support all 50 state health departments, many local health departments, Guam, Puerto Rico, and the U.S. Virgin Islands in 2020. From 2016 to 2022, the CDC invested in over 500 novel antimicrobial resistance programs in over 50 countries to prevent the spread of resistance both locally and globally. The well-established awareness campaigns for precision medicine and the use of antimicrobial testing, advantageous government initiatives, and a rising number of collaborative researches are some of the anticipated market growth drivers.

The US market dominated the North America Antimicrobial Susceptibility Testing Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $1,293 million by 2028. The Canada market is poised to grow at a CAGR of 7.8% during (2022 - 2028). Additionally, The Mexico market would witness a CAGR of 6.9% during (2022 - 2028).

Based on Application, the market is segmented into Clinical Diagnostics, Drug Discovery & Development and Epidemiology & Others. Based on Method, the market is segmented into Automated Susceptibility Testing Instruments, Disk Diffusion, Etest Method, Agar Diffusion, and Genotyping Method. Based on Type, the market is segmented into Antibacterial, Antifungal, Antiparasitic, and Others. Based on End User, the market is segmented into Hospitals & Diagnostic centers, Pharmaceutical & Biotechnology Companies, Research & Academic Institutes, and Clinical Research Organizations. Based on Product, the market is segmented into Automated Laboratory Instruments, Manual Laboratory Instruments, Culture & Growth Media and Consumables. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include BioMerieux S.A., Becton, Dickinson and Company, Thermo Fisher Scientific, Inc., Danaher Corporation, Bio-Rad Laboratories, Inc., Merck KGaA, Bruker Corporation, Accelerate Diagnostics, Inc., HiMedia Laboratories Pvt. Ltd., and F. Hoffmann-La Roche Ltd.

Scope of the Study

Market Segments covered in the Report:

By Application

  • Clinical Diagnostics
  • Drug Discovery & Development
  • Epidemiology & Others

By Method

  • Automated Susceptibility Testing Instruments
  • Disk Diffusion
  • Etest Method
  • Agar Diffusion
  • Genotyping Method

By Type

  • Antibacterial
  • Antifungal
  • Antiparasitic
  • Others

By End User

  • Hospitals & Diagnostic centers
  • Pharmaceutical & Biotechnology Companies
  • Research & Academic Institutes
  • Clinical Research Organizations

By Product

  • Automated Laboratory Instruments
  • Manual Laboratory Instruments
  • Culture & Growth Media
  • Consumables

By Country

  • US
  • Canada
  • Mexico
  • Rest of North America

Companies Profiled

  • BioMerieux S.A.
  • Becton, Dickinson and Company
  • Thermo Fisher Scientific, Inc.
  • Danaher Corporation
  • Bio-Rad Laboratories, Inc.
  • Merck KGaA
  • Bruker Corporation
  • Accelerate Diagnostics, Inc.
  • HiMedia Laboratories Pvt. Ltd.
  • F. Hoffmann-La Roche Ltd.

Unique Offerings from KBV Research

  • Exhaustive coverage
  • Highest number of market tables and figures
  • Subscription based model available
  • Guaranteed best price
  • Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

  • 1.1 Market Definition
  • 1.2 Objectives
  • 1.3 Market Scope
  • 1.4 Segmentation
    • 1.4.1 North America Antimicrobial Susceptibility Testing Market, by Application
    • 1.4.2 North America Antimicrobial Susceptibility Testing Market, by Method
    • 1.4.3 North America Antimicrobial Susceptibility Testing Market, by Type
    • 1.4.4 North America Antimicrobial Susceptibility Testing Market, by End User
    • 1.4.5 North America Antimicrobial Susceptibility Testing Market, by Product
    • 1.4.6 North America Antimicrobial Susceptibility Testing Market, by Country
  • 1.5 Methodology for the research

Chapter 2. Market Overview

  • 2.1 Introduction
    • 2.1.1 Overview
      • 2.1.1.1 Market Composition &Scenario
  • 2.2 Key Factors Impacting the Market
    • 2.2.1 Market Drivers
    • 2.2.2 Market Restraints

Chapter 3. Strategies Deployed in Antimicrobial Susceptibility Testing Market

Chapter 4. North America Antimicrobial Susceptibility Testing Market by Application

  • 4.1 North America Clinical Diagnostics Market by Country
  • 4.2 North America Drug Discovery & Development Market by Country
  • 4.3 North America Epidemiology & Others Market by Country

Chapter 5. North America Antimicrobial Susceptibility Testing Market by Method

  • 5.1 North America Automated Susceptibility Testing Instruments Market by Country
  • 5.2 North America Disk Diffusion Market by Country
  • 5.3 North America Etest Method Market by Country
  • 5.4 North America Agar Diffusion Market by Country
  • 5.5 North America Genotyping Method Market by Country

Chapter 6. North America Antimicrobial Susceptibility Testing Market by Type

  • 6.1 North America Antibacterial Market by Country
  • 6.2 North America Antifungal Market by Country
  • 6.3 North America Antiparasitic Market by Country
  • 6.4 North America Others Market by Country

Chapter 7. North America Antimicrobial Susceptibility Testing Market by End User

  • 7.1 North America Hospitals & Diagnostic centers Market by Country
  • 7.2 North America Pharmaceutical & Biotechnology Companies Market by Country
  • 7.3 North America Research & Academic Institutes Market by Country
  • 7.4 North America Clinical Research Organizations Market by Country

Chapter 8. North America Antimicrobial Susceptibility Testing Market by Product

  • 8.1 North America Automated Laboratory Instruments Market by Country
  • 8.2 North America Manual Laboratory Instruments Market by Country
  • 8.3 North America Culture & Growth Media Market by Country
  • 8.4 North America Consumables Market by Country

Chapter 9. North America Antimicrobial Susceptibility Testing Market by Country

  • 9.1 US Antimicrobial Susceptibility Testing Market
    • 9.1.1 US Antimicrobial Susceptibility Testing Market by Application
    • 9.1.2 US Antimicrobial Susceptibility Testing Market by Method
    • 9.1.3 US Antimicrobial Susceptibility Testing Market by Type
    • 9.1.4 US Antimicrobial Susceptibility Testing Market by End User
    • 9.1.5 US Antimicrobial Susceptibility Testing Market by Product
  • 9.2 Canada Antimicrobial Susceptibility Testing Market
    • 9.2.1 Canada Antimicrobial Susceptibility Testing Market by Application
    • 9.2.2 Canada Antimicrobial Susceptibility Testing Market by Method
    • 9.2.3 Canada Antimicrobial Susceptibility Testing Market by Type
    • 9.2.4 Canada Antimicrobial Susceptibility Testing Market by End User
    • 9.2.5 Canada Antimicrobial Susceptibility Testing Market by Product
  • 9.3 Mexico Antimicrobial Susceptibility Testing Market
    • 9.3.1 Mexico Antimicrobial Susceptibility Testing Market by Application
    • 9.3.2 Mexico Antimicrobial Susceptibility Testing Market by Method
    • 9.3.3 Mexico Antimicrobial Susceptibility Testing Market by Type
    • 9.3.4 Mexico Antimicrobial Susceptibility Testing Market by End User
    • 9.3.5 Mexico Antimicrobial Susceptibility Testing Market by Product
  • 9.4 Rest of North America Antimicrobial Susceptibility Testing Market
    • 9.4.1 Rest of North America Antimicrobial Susceptibility Testing Market by Application
    • 9.4.2 Rest of North America Antimicrobial Susceptibility Testing Market by Method
    • 9.4.3 Rest of North America Antimicrobial Susceptibility Testing Market by Type
    • 9.4.4 Rest of North America Antimicrobial Susceptibility Testing Market by End User
    • 9.4.5 Rest of North America Antimicrobial Susceptibility Testing Market by Product

Chapter 10. Company Profiles

  • 10.1 Bruker Corporation
    • 10.1.1 Company Overview
    • 10.1.2 Financial Analysis
    • 10.1.3 Segmental and Regional Analysis
    • 10.1.4 Research & Development Expense
    • 10.1.5 Recent strategies and developments:
      • 10.1.5.1 Product Launches and Product Expansions:
      • 10.1.5.2 Acquisition and Mergers:
  • 10.2 BioMerieux S.A.
    • 10.2.1 Company Overview
    • 10.2.2 Financial Analysis
    • 10.2.3 Segmental and Regional Analysis
    • 10.2.4 Research & Development Expenses
    • 10.2.5 Recent strategies and developments:
      • 10.2.5.1 Acquisition and Mergers:
      • 10.2.5.2 Approvals and Trials:
  • 10.3 Becton, Dickinson and Company
    • 10.3.1 Company Overview
    • 10.3.2 Financial Analysis
    • 10.3.3 Segmental and Regional Analysis
    • 10.3.4 Research & Development Expense
    • 10.3.5 Recent strategies and developments:
      • 10.3.5.1 Partnerships, Collaborations, and Agreements:
  • 10.4 Accelerate Diagnostics, Inc.
    • 10.4.1 Company Overview
    • 10.4.2 Financial Analysis
    • 10.4.3 Regional Analysis
    • 10.4.4 Research & Development Expenses
    • 10.4.5 Recent strategies and developments:
      • 10.4.5.1 Product Launches and Product Expansions:
      • 10.4.5.2 Approvals and Trials:
  • 10.5 Thermo Fisher Scientific, Inc.
    • 10.5.1 Company Overview
    • 10.5.2 Financial Analysis
    • 10.5.3 Segmental and Regional Analysis
    • 10.5.4 Research & Development Expenses
    • 10.5.5 Recent strategies and developments:
      • 10.5.5.1 Product Launches and Product Expansions:
  • 10.6 Danaher Corporation
    • 10.6.1 Company Overview
    • 10.6.2 Financial Analysis
    • 10.6.3 Segmental and Regional Analysis
    • 10.6.4 Research & Development Expense
  • 10.7 Bio-Rad laboratories, Inc.
    • 10.7.1 Company Overview
    • 10.7.2 Financial Analysis
    • 10.7.3 Segmental and Regional Analysis
    • 10.7.4 Research & Development Expenses
    • 10.7.5 Recent strategies and developments:
      • 10.7.5.1 Acquisition and Mergers:
  • 10.8 Merck KGaA
    • 10.8.1 Company Overview
    • 10.8.2 Financial Analysis
    • 10.8.3 Segmental and Regional Analysis
    • 10.8.4 Research & Development Expense
  • 10.9 F. Hoffmann-La Roche Ltd.
    • 10.9.1 Company Overview
    • 10.9.2 Financial Analysis
    • 10.9.3 Segmental and Regional Analysis
    • 10.9.4 Research & Development Expense
  • 10.10. HiMedia Laboratories Pvt. Ltd.
    • 10.10.1 Company Overview

LIST OF TABLES

  • TABLE 1 North America Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
  • TABLE 2 North America Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
  • TABLE 3 North America Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 4 North America Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 5 North America Clinical Diagnostics Market by Country, 2018 - 2021, USD Million
  • TABLE 6 North America Clinical Diagnostics Market by Country, 2022 - 2028, USD Million
  • TABLE 7 North America Drug Discovery & Development Market by Country, 2018 - 2021, USD Million
  • TABLE 8 North America Drug Discovery & Development Market by Country, 2022 - 2028, USD Million
  • TABLE 9 North America Epidemiology & Others Market by Country, 2018 - 2021, USD Million
  • TABLE 10 North America Epidemiology & Others Market by Country, 2022 - 2028, USD Million
  • TABLE 11 North America Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
  • TABLE 12 North America Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
  • TABLE 13 North America Automated Susceptibility Testing Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 14 North America Automated Susceptibility Testing Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 15 North America Disk Diffusion Market by Country, 2018 - 2021, USD Million
  • TABLE 16 North America Disk Diffusion Market by Country, 2022 - 2028, USD Million
  • TABLE 17 North America Etest Method Market by Country, 2018 - 2021, USD Million
  • TABLE 18 North America Etest Method Market by Country, 2022 - 2028, USD Million
  • TABLE 19 North America Agar Diffusion Market by Country, 2018 - 2021, USD Million
  • TABLE 20 North America Agar Diffusion Market by Country, 2022 - 2028, USD Million
  • TABLE 21 North America Genotyping Method Market by Country, 2018 - 2021, USD Million
  • TABLE 22 North America Genotyping Method Market by Country, 2022 - 2028, USD Million
  • TABLE 23 North America Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 24 North America Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 25 North America Antibacterial Market by Country, 2018 - 2021, USD Million
  • TABLE 26 North America Antibacterial Market by Country, 2022 - 2028, USD Million
  • TABLE 27 North America Antifungal Market by Country, 2018 - 2021, USD Million
  • TABLE 28 North America Antifungal Market by Country, 2022 - 2028, USD Million
  • TABLE 29 North America Antiparasitic Market by Country, 2018 - 2021, USD Million
  • TABLE 30 North America Antiparasitic Market by Country, 2022 - 2028, USD Million
  • TABLE 31 North America Others Market by Country, 2018 - 2021, USD Million
  • TABLE 32 North America Others Market by Country, 2022 - 2028, USD Million
  • TABLE 33 North America Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 34 North America Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 35 North America Hospitals & Diagnostic centers Market by Country, 2018 - 2021, USD Million
  • TABLE 36 North America Hospitals & Diagnostic centers Market by Country, 2022 - 2028, USD Million
  • TABLE 37 North America Pharmaceutical & Biotechnology Companies Market by Country, 2018 - 2021, USD Million
  • TABLE 38 North America Pharmaceutical & Biotechnology Companies Market by Country, 2022 - 2028, USD Million
  • TABLE 39 North America Research & Academic Institutes Market by Country, 2018 - 2021, USD Million
  • TABLE 40 North America Research & Academic Institutes Market by Country, 2022 - 2028, USD Million
  • TABLE 41 North America Clinical Research Organizations Market by Country, 2018 - 2021, USD Million
  • TABLE 42 North America Clinical Research Organizations Market by Country, 2022 - 2028, USD Million
  • TABLE 43 North America Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 44 North America Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 45 North America Automated Laboratory Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 46 North America Automated Laboratory Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 47 North America Manual Laboratory Instruments Market by Country, 2018 - 2021, USD Million
  • TABLE 48 North America Manual Laboratory Instruments Market by Country, 2022 - 2028, USD Million
  • TABLE 49 North America Culture & Growth Media Market by Country, 2018 - 2021, USD Million
  • TABLE 50 North America Culture & Growth Media Market by Country, 2022 - 2028, USD Million
  • TABLE 51 North America Consumables Market by Country, 2018 - 2021, USD Million
  • TABLE 52 North America Consumables Market by Country, 2022 - 2028, USD Million
  • TABLE 53 North America Antimicrobial Susceptibility Testing Market by Country, 2018 - 2021, USD Million
  • TABLE 54 North America Antimicrobial Susceptibility Testing Market by Country, 2022 - 2028, USD Million
  • TABLE 55 US Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
  • TABLE 56 US Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
  • TABLE 57 US Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 58 US Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 59 US Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
  • TABLE 60 US Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
  • TABLE 61 US Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 62 US Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 63 US Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 64 US Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 65 US Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 66 US Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 67 Canada Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
  • TABLE 68 Canada Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
  • TABLE 69 Canada Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 70 Canada Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 71 Canada Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
  • TABLE 72 Canada Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
  • TABLE 73 Canada Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 74 Canada Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 75 Canada Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 76 Canada Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 77 Canada Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 78 Canada Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 79 Mexico Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
  • TABLE 80 Mexico Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
  • TABLE 81 Mexico Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 82 Mexico Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 83 Mexico Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
  • TABLE 84 Mexico Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
  • TABLE 85 Mexico Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 86 Mexico Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 87 Mexico Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 88 Mexico Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 89 Mexico Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 90 Mexico Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 91 Rest of North America Antimicrobial Susceptibility Testing Market, 2018 - 2021, USD Million
  • TABLE 92 Rest of North America Antimicrobial Susceptibility Testing Market, 2022 - 2028, USD Million
  • TABLE 93 Rest of North America Antimicrobial Susceptibility Testing Market by Application, 2018 - 2021, USD Million
  • TABLE 94 Rest of North America Antimicrobial Susceptibility Testing Market by Application, 2022 - 2028, USD Million
  • TABLE 95 Rest of North America Antimicrobial Susceptibility Testing Market by Method, 2018 - 2021, USD Million
  • TABLE 96 Rest of North America Antimicrobial Susceptibility Testing Market by Method, 2022 - 2028, USD Million
  • TABLE 97 Rest of North America Antimicrobial Susceptibility Testing Market by Type, 2018 - 2021, USD Million
  • TABLE 98 Rest of North America Antimicrobial Susceptibility Testing Market by Type, 2022 - 2028, USD Million
  • TABLE 99 Rest of North America Antimicrobial Susceptibility Testing Market by End User, 2018 - 2021, USD Million
  • TABLE 100 Rest of North America Antimicrobial Susceptibility Testing Market by End User, 2022 - 2028, USD Million
  • TABLE 101 Rest of North America Antimicrobial Susceptibility Testing Market by Product, 2018 - 2021, USD Million
  • TABLE 102 Rest of North America Antimicrobial Susceptibility Testing Market by Product, 2022 - 2028, USD Million
  • TABLE 103 Key Information - Bruker Corporation
  • TABLE 104 Key information - BioMerieux S.A.
  • TABLE 105 Key information - Becton, Dickinson and Company
  • TABLE 106 Key Information - Accelerate Diagnostics, Inc.
  • TABLE 107 Key Information - Thermo Fisher Scientific, Inc.
  • TABLE 108 Key Information - Danaher Corporation
  • TABLE 109 Key Information - Bio-Rad Laboratories, Inc.
  • TABLE 110 key Information - Merck KGaA
  • TABLE 111 KEY INFORMATION - F. Hoffmann-La Roche Ltd.
  • TABLE 112 Key Information - HiMedia Laboratories Pvt. Ltd.

List of Figures

  • FIG 1 Methodology for the research
Have a question?
Picture

Jeroen Van Heghe

Manager - EMEA

+32-2-535-7543

Picture

Christine Sirois

Manager - Americas

+1-860-674-8796

Questions? Please give us a call or visit the contact form.
Hi, how can we help?
Contact us!